Focal cryoablation for unilateral low-intermediate-risk prostate cancer: 63-month mean follow-up results of 41 patients

详细信息    查看全文

• 作者：Huibo Lian ; Junlong Zhuang ; Rong Yang ; Feng Qu…
• 关键词：Prostatic neoplasms ; Carcinoma ; Cryoablation ; Focal
• 刊名：International Urology and Nephrology
• 出版年：2016
• 出版时间：January 2016
• 年：2016
• 卷：48
• 期：1
• 页码：85-90
• 全文大小：417 KB
• 参考文献：1.Cooperberg MR, Lubeck DP, Meng MV et al (2004) The changing face of low-risk prostate cancer: trends in clinical presentation and primary management. J Clin Oncol 22:2141–2149PubMed PubMedCentral CrossRef
  2.Hayes JH, Ollendorf DA, Pearson SD et al (2010) Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis. JAMA 304:2373–2380PubMed PubMedCentral CrossRef
  3.Eggener SE, Scardino PT, Carroll PR et al (2007) Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. J Urol 178:2260–2267PubMed CrossRef
  4.Onik G, Vaughan D, Lotenfoe R et al (2008) The “male lumpectomy”: focal therapy for prostate cancer using cryoablation results in 48 patients with at least 2-year follow-up. Urol Oncol 26:500–505PubMed CrossRef
  5.Truesdale MD, Cheetham PJ, Hruby GW et al (2010) An evaluation of patient selection criteria on predicting progression-free survival after primary focal unilateral nerve-sparing cryoablation for prostate cancer: recommendations for follow up. Cancer J 16:544–549PubMed CrossRef
  6.Bahn D, de Castro Abreu AL, Gill IS et al (2012) Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years. Eur Urol 62:55–63PubMed CrossRef
  7.Durand M, Barret E, Galiano M et al (2014) Focal cryoablation: a treatment option for unilateral low-risk prostate cancer. BJU Int 113(1):56–64PubMed CrossRef
  8.Lian H, Guo H, Gan W et al (2011) Cryosurgery as primary treatment for localized prostate cancer. Int Urol Nephrol 43:1089–1094PubMed CrossRef
  9.Williams SG, Duchesne GM, Gogna NK et al (2006) An international multicenter study evaluating the impact of an alternative biochemical failure definition on the judgment of prostate cancer risk. Int J Radiat Oncol Biol Phys 65:351–357PubMed CrossRef
  10.Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213PubMed PubMedCentral CrossRef
  11.Sartor AO, Hricak H, Wheeler TM et al (2008) Evaluating localized prostate cancer and identifying candidates for focal therapy. Urology 72:S12–S24PubMed CrossRef
  12.Prepelica KL, Okeke Z, Murphy A et al (2005) Cryosurgical ablation of the prostate: high risk patient outcomes. Cancer 103:1625–1630PubMed CrossRef
  13.Bahn DK, Silverman P, Lee F Sr et al (2006) Focal prostate cryoablation: initial results show cancer control and potency preservation. J Endourol 20:688–692PubMed CrossRef
  14.Lambert EH, Bolte K, Masson P et al (2007) Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer. Urology 69:1117–1120PubMed CrossRef
  15.Potosky AL, Haque R, Cassidy-Bushrow AE et al (2014) Effectiveness of primary androgen-deprivation therapy for clinically localized prostate cancer. J Clin Oncol 32:1324–1330PubMed PubMedCentral CrossRef
  16.Wilt TJ, Brawer MK, Jones KM et al (2012) Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 367:203–213PubMed PubMedCentral CrossRef
  17.Massimo V, Hashim UA, Mark E et al (2014) The role of focal therapy in the management of localised prostate cancer: a systematic review. Eur Urol 66:732–751CrossRef
  18.Bostwick DG, Waters DJ, Farley ER et al (2007) Group consensus reports from the consensus conference on focal treatment of prostatic carcinoma. Urology 70(Suppl):42–44PubMed CrossRef
  19.Jayram G, Eggener SE (2009) Patient selection for focal therapy of localized prostate cancer. Curr Opin Urol 19:268–273PubMed CrossRef
  20.Amling CL, Bergstrahl EJ, Blute ML et al (2001) Defining prostate specific antigen progression after radical prostatectomy: What is the most appropriate cut point? J Urol 165:1146–1151PubMed CrossRef
  21.American Society for Therapeutic Radiology and Oncology Consensus (1997) Panel: consensus statement: guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 37:1035–1041
  22.D’Amico AV, Schultz D, Lofreddo M et al (2000) Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for clinically localized prostate cancer. JAMA 284:1280–1283PubMed CrossRef
  
• 作者单位：Huibo Lian (1)
  Junlong Zhuang (1)
  Rong Yang (1)
  Feng Qu (1)
  Wei Wang (1)
  Tingsheng Lin (1)
  Hongqian Guo (1)
  
  1. Department of Urology, Affiliated Drum Tower Hospital of Nanjing University, 321 Zhongshan Road, Nanjing, 210008, People’s Republic of China
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Nephrology
  Urology and Andrology
  
• 出版者：Springer Netherlands
• ISSN：1573-2584

文摘

Objective To report (1) intermediate-term oncologic and functional outcomes of primary focal cryoablation (FC) in selected patients with clinically unilateral, low-intermediate-risk prostate cancer, and investigate (2) the impact of patient selection criteria at predicting outcomes after FC.